JANUARY 28–29, 2014 | RITZ CARLTON | WASHINGTON, DC
100+ Industry Experts. 50+ Sessions. 1 Choice for Compliance. |
Widely recognized as the most comprehensive, senior-level compliance meeting, CBI's esteemed Pharmaceutical Compliance Congress (PCC) attracts more than 400 industry leaders, including dozens of CCOs and their legal, compliance and regulatory teams. With unmatched, an expert speaking faculty and the who’s who in compliance in attendance, PCC is the must-attend event for your organization in 2014!
Delivering the most robust agenda to date, PCC features insight from more than two dozen CCOs and first-hand feedback from government agencies, including DOJ, FDA and U.S. Attorneys.
Just Added to the Agenda – Stuart F. Delery, Assistant Attorney General, Civil Division, The United States Department of Justice
Program Highlights:
- The in-depth agenda was built with specific functional responsibilities in mind — monitoring, training, investigations, R&D compliance and so much more!
- Dedicated, high-level content for senior-level professionals, as well as fundamental sessions tailored to those new to the compliance space
- Pertinent, pressing issues facing compliance professionals, such as FCPA, considerations for BRIC nations, compliance for specialty products, third-party investigations and more!
- The ever-popular Enforcement Panel, this year featuring DOJ and U.S. Attorneys representing Pennsylvania, South Carolina, Oklahoma, New York and Tennessee…and Massachusetts’ Carmen Ortiz delivers an Address on High Priority Areas for 2014
- CCOs representing Aegerion, AstraZeneca, Daiichi, Regeneron and Sunovion unite for a can’t miss panel on Achieving a True Culture of Compliance
- And much, much more! Register now or download the full brochure instantly